BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li Y, Zhai Y, Liu W, Zhang K, Liu J, Shi J, Zhang Z. Ultrasmall nanostructured drug based pH-sensitive liposome for effective treatment of drug-resistant tumor. J Nanobiotechnology 2019;17:117. [PMID: 31783863 DOI: 10.1186/s12951-019-0550-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Duarte JA, Gomes ER, De Barros ALB, Leite EA. Co-Encapsulation of Simvastatin and Doxorubicin into pH-Sensitive Liposomes Enhances Antitumoral Activity in Breast Cancer Cell Lines. Pharmaceutics 2023;15:369. [DOI: 10.3390/pharmaceutics15020369] [Reference Citation Analysis]
2 Yunfeng Lin, Qian Li, Lihua Wang, Quanyi Guo, Shuyun Liu, Shihui Zhu, Yu Sun, Yujiang Fan, Yong Sun, Haihang Li, Xudong Tian, Delun Luo, Sirong Shi. Advances in regenerative medicine applications of tetrahedral framework nucleic acid-based nanomaterials: an expert consensus recommendation. Int J Oral Sci 2022;14:51. [PMID: 36316311 DOI: 10.1038/s41368-022-00199-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Cheng X, Yan H, Pang S, Ya M, Qiu F, Qin P, Zeng C, Lu Y. Liposomes as Multifunctional Nano-Carriers for Medicinal Natural Products. Front Chem 2022;10:963004. [DOI: 10.3389/fchem.2022.963004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Zhao T, Liang C, Zhao Y, Xue X, Ma Z, Qi J, Shen H, Yang S, Zhang J, Jia Q, Du Q, Cao D, Xiang B, Zhang H, Qi X. Multistage pH-responsive codelivery liposomal platform for synergistic cancer therapy. J Nanobiotechnol 2022;20. [DOI: 10.1186/s12951-022-01383-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Zhang C, Zhou X, Zhang H, Han X, Li B, Yang R, Zhou X. Recent Progress of Novel Nanotechnology Challenging the Multidrug Resistance of Cancer. Front Pharmacol 2022;13:776895. [DOI: 10.3389/fphar.2022.776895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
6 Li Z, Liu C, Li C, Wang F, Liu J, Zheng Z, Wu J, Zhang B. Irinotecan/scFv co-loaded liposomes coaction on tumor cells and CAFs for enhanced colorectal cancer therapy. J Nanobiotechnology 2021;19:421. [PMID: 34906155 DOI: 10.1186/s12951-021-01172-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Zong W, Shao X, Chai Y, Wang X, Han S, Chu H, Zhu C, Zhang X. Liposomes encapsulating artificial cytosol as drug delivery system. Biophys Chem 2021;281:106728. [PMID: 34864227 DOI: 10.1016/j.bpc.2021.106728] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Zhang T, Tian T, Lin Y. Functionalizing Framework Nucleic-Acid-Based Nanostructures for Biomedical Application. Adv Mater 2021;:e2107820. [PMID: 34787933 DOI: 10.1002/adma.202107820] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 26.0] [Reference Citation Analysis]
9 Yao W, Liu C, Wang N, Zhou H, Chen H, Qiao W. Anisamide-modified dual-responsive drug delivery system with MRI capacity for cancer targeting therapy. Journal of Molecular Liquids 2021;340:116889. [DOI: 10.1016/j.molliq.2021.116889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ward DM, Shodeinde AB, Peppas NA. Innovations in Biomaterial Design toward Successful RNA Interference Therapy for Cancer Treatment. Adv Healthc Mater 2021;10:e2100350. [PMID: 33973393 DOI: 10.1002/adhm.202100350] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
11 Liu M, Ma W, Zhao D, Li J, Li Q, Liu Y, Hao L, Lin Y. Enhanced Penetrability of a Tetrahedral Framework Nucleic Acid by Modification with iRGD for DOX-Targeted Delivery to Triple-Negative Breast Cancer. ACS Appl Mater Interfaces 2021;13:25825-35. [PMID: 34038071 DOI: 10.1021/acsami.1c07297] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
12 Shao J, Liang R, Ding D, Zheng X, Zhu X, Hu S, Wei H, Wei B. A Smart Multifunctional Nanoparticle for Enhanced Near-Infrared Image-Guided Photothermal Therapy Against Gastric Cancer. Int J Nanomedicine 2021;16:2897-915. [PMID: 33907399 DOI: 10.2147/IJN.S289310] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
13 Yao W, Liu C, Wang N, Zhou H, Chen H, Qiao W. Triple-responsive targeted hybrid liposomes with high MRI performance for tumor diagnosis and therapy. Mater Chem Front 2021;5:6226-43. [DOI: 10.1039/d1qm00788b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Abdullah CS, Ray P, Alam S, Kale N, Aishwarya R, Morshed M, Dutta D, Hudziak C, Banerjee SK, Mallik S, Banerjee S, Bhuiyan MS, Quadir M. Chemical Architecture of Block Copolymers Differentially Abrogate Cardiotoxicity and Maintain the Anticancer Efficacy of Doxorubicin. Mol Pharm 2020;17:4676-90. [PMID: 33151075 DOI: 10.1021/acs.molpharmaceut.0c00963] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
15 Shao J, Zheng X, Feng L, Lan T, Ding D, Cai Z, Zhu X, Liang R, Wei B. Targeting Fluorescence Imaging of RGD-Modified Indocyanine Green Micelles on Gastric Cancer. Front Bioeng Biotechnol 2020;8:575365. [PMID: 33102459 DOI: 10.3389/fbioe.2020.575365] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]